Sango Skelem
Overview
Explore the profile of Sango Skelem including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
683
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benede N, Tincho M, Walters A, Subbiah V, Ngomti A, Baguma R, et al.
iScience
. 2024 Jan;
27(1):108728.
PMID: 38235336
SARS-CoV-2 infection in children typically results in asymptomatic or mild disease. There is a paucity of studies on SARS-CoV-2 antiviral immunity in African children. We investigated SARS-CoV-2-specific T cell responses...
2.
Nesamari R, Omondi M, Baguma R, Hoft M, Ngomti A, Nkayi A, et al.
Cell Host Microbe
. 2024 Jan;
32(2):162-169.e3.
PMID: 38211583
Ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolution has given rise to recombinant Omicron lineages that dominate globally (XBB.1), as well as the emergence of hypermutated variants (BA.2.86). In...
3.
Moyo-Gwete T, Richardson S, Keeton R, Hermanus T, Spencer H, Manamela N, et al.
PLoS Pathog
. 2023 Nov;
19(11):e1011772.
PMID: 37943890
The impact of previous SARS-CoV-2 infection on the durability of Ad26.COV2.S vaccine-elicited responses, and the effect of homologous boosting has not been well explored. We followed a cohort of healthcare...
4.
Krause R, Moyo-Gwete T, Richardson S, Makhado Z, Manamela N, Hermanus T, et al.
NPJ Vaccines
. 2023 Aug;
8(1):119.
PMID: 37573434
Neutralizing antibodies strongly correlate with protection for COVID-19 vaccines, but the corresponding memory B cells that form to protect against future infection are relatively understudied. Here we examine the effect...
5.
Benede N, Tincho M, Walters A, Subbiah V, Ngomti A, Baguma R, et al.
medRxiv
. 2023 Jun;
PMID: 37292954
SARS-CoV-2 infection in children typically results in asymptomatic or mild disease. There is a paucity of studies on antiviral immunity in African children. We investigated SARS-CoV-2-specific T cell responses in...
6.
Moyo-Gwete T, Richardson S, Keeton R, Hermanus T, Spencer H, Manamela N, et al.
medRxiv
. 2023 Mar;
PMID: 36993404
The impact of previous SARS-CoV-2 infection on the durability of Ad26.COV2.S vaccine-elicited responses, and the effect of homologous boosting has not been well explored. We followed a cohort of healthcare...
7.
Keeton R, Tincho M, Suzuki A, Benede N, Ngomti A, Baguma R, et al.
Cell Rep Med
. 2022 Dec;
4(1):100898.
PMID: 36584684
Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposures, from infection or vaccination, can potently boost spike antibody responses. Less is known about the impact of repeated exposures on T ...
8.
Kitchin D, Richardson S, van der Mescht M, Motlou T, Mzindle N, Moyo-Gwete T, et al.
Cell Rep Med
. 2022 Apr;
3(3):100535.
PMID: 35474744
The Janssen (Johnson & Johnson) Ad26.COV2.S non-replicating viral vector vaccine has been widely deployed for COVID-19 vaccination programs in resource-limited settings. Here we confirm that neutralizing and binding antibody responses...
9.
Keeton R, Tincho M, Ngomti A, Baguma R, Benede N, Suzuki A, et al.
Nature
. 2022 Apr;
604(7907):E25.
PMID: 35396582
No abstract available.
10.
Richardson S, Manamela N, Motsoeneng B, Kaldine H, Ayres F, Makhado Z, et al.
Cell Rep Med
. 2022 Mar;
3(2):100510.
PMID: 35233544
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants of concern (VOCs) exhibit escape from neutralizing antibodies, causing concern about vaccine effectiveness. However, while non-neutralizing cytotoxic functions of antibodies are associated with...